Consensus statement: Octreotide dose titration in secretory diarrhea
- 1 July 1995
- journal article
- review article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 40 (7), 1464-1473
- https://doi.org/10.1007/bf02285194
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Control of Chemotherapy-Induced Diarrhea with OctreotideOncology, 1994
- Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapyAnti-Cancer Drugs, 1993
- Somatostatin Analogue Therapy in Functioning Neuroendocrine Gut TumorsDigestion, 1993
- Octreotide in Dumping and Short Bowel SyndromesDigestion, 1993
- Effective treatment of diabetic diarrhoea with somatostatin analogue, octreotide.Gut, 1992
- Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implicationsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Control of chemotherapy-induced diarrhoea with octreotide in patients receiving 5-fluorouracilEuropean Journal Of Cancer, 1992
- Peptides of human immunodeficiency virus (HIV) evoke rat colonic electrolyte secretion inhibitable by the somatostatin analog octreotideLife Sciences, 1991
- Severe Diarrhea after Colonic Pseudo-Obstruction: Treatment with SomatostatinNew England Journal of Medicine, 1984
- Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic choleraDigestive Diseases and Sciences, 1982